Skip to main content

Featured

Rising Tensions: Reports Hint at Possible U.S. Move Toward Iran

In this frame grab from footage circulating on social media from Iran, protesters once again take to the streets of Tehran despite an intensifying crackdown as the Islamic Republic remains cut off from the rest of the world in Tehran, Iran, January 10, 2026. Regional tensions have intensified as Israeli officials place the country on heightened alert amid growing speculation that the United States may be preparing to take action involving Iran. The shift comes at a moment when Iran is facing widespread domestic unrest, with demonstrations erupting across major cities and drawing international attention. Washington has issued increasingly sharp warnings to Iran’s leadership about the use of force against protesters, emphasizing that the U.S. is monitoring the situation closely. While American officials have not confirmed any operational plans, the possibility of U.S. involvement is being taken seriously by regional governments. The heightened alert follows a period of volatility mark...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment